Risk factors and clinical manifestations in patients with pulmonary infections caused by nontuberculous mycobacteria.
DOI:
https://doi.org/10.52692/1857-0011.2025.3-83.11Keywords:
mycobacteriosis, MAC, M. kansasii, COPDAbstract
The incidence of pulmonary infection with NTM increases with age and varies significantly between countries. NTMs are opportunistic pathogens that cause disease, especially in immunocompromised patients or with pre-existing lung disease. In 2021-2024, 22 patients with pulmonary mycobacteriosis were admitted to the MCHP. The majority of patients were men, MAC predominated, followed by M. kansasii. Risk factors included the medical-biological, HIV- infection, respiratory system pathology, harmful habits, hystory of tuberculosis (TB). Age over 51 years old had 50% of the patients. History of TB had 1/3 of the patients. Among the associated diseases the respiratory system diseases predominated (86,4%): COPD, bronchiectasis, neoplastic processes, othres. Diagnosis was estableshed in the period up 2 weeeks from hospitalisation in 68,8% cases. Clinical picture were presented by bronchopulmonary, toxico-infection syndromes.
References
Babalik A, Koç EN, Sekerbey HG, et al. Nontuberculous mycobacteria isolation from sputum specimens: A retrospective analysis of 1061 cases. Int J Mycobacteriol. 2023;12(1):55-65.
Dhasmana DJ, Whitaker P, et al. A practical guide to the diagnosis and management of suspected Non- tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom. NPJ Prim Care Respir Med. 2024 21;34(1):45.
Ratnatunga CN, Lutzky VP, Kupz A, et al. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol. 2020, 3;11:303.
Thornton, C. S., Mellett, M., Jarand, et al. The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health. Eur. Respir. Rev. 2020, 30 (160), 200299.
Wang DM, Liu H, et al. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022. Front Cell Infect Microbiol. 2023, 31;13:1282902.
Weng YW, Huang CK, Sy CL, et al. Treatment for Mycobacterium abscessus complex-lung disease. J Formos Med Assoc. 2020;119 Suppl 1:S58-S66.
Zhou, L., Xu, D., et al. Trends in the prevalence and antibiotic resistance of non-tuberculous mycobacteria in mainland China, 2000-2019: systematic review and meta-analysis. Front. Public Health. 2020, 8: 295.
Downloads
Published
License
Copyright (c) 2026 Bulletin of the Academy of Sciences of Moldova. Medical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
